Dw. Rufael et Se. Cohn, NATIVE VALVE ENDOCARDITIS DUE TO CORYNEBACTERIUM-STRIATUM - CASE-REPORT AND REVIEW, Clinical infectious diseases, 19(6), 1994, pp. 1054-1061
We report the first known case of native valve endocarditis due to Cor
ynebacterium striatum and review 51 previously reported cases of nativ
e valve endocarditis due to non-diphtheriae corynebacteria. Of the 52
patients with corynebacterial endocarditis, 11 (21%) had no predisposi
ng conditions and 27 (52%) had structural heart disease; endocarditis
in the remaining 14 patients (27%) was associated with noncardiac pred
isposing factors including injection drug use, chronic hemodialysis, v
asculitis, alcoholism, liver transplantation and hemodialysis, a perit
oneovenous shunt, and prior aspiration of a noninfected bursa. The mor
tality rate associated with corynebacterial endocarditis was 31%. The
majority of corynebacteria in this series were sensitive to penicillin
, erythromycin, gentamicin, and vancomycin. Non-diphtheriae corynebact
eria are capable of producing acute valvular damage, even in patients
without conditions that are predisposing for endocarditis. The occurre
nce of bacteremia due to non-diphtheriae corynebacteria in the appropr
iate clinical setting should alert physicians to the possible diagnosi
s of endocarditis. Empirical antibiotic therapy with vancomycin, with
or without an aminoglycoside, should be initiated pending antibiotic s
usceptibility testing.